Symbol
| RYR1
| contributors: mct - updated : 31-08-2018
|
HGNC name
| ryanodine receptor 1 (skeletal)
|
HGNC id
| 10483
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
| loss of function
|
altered RYR1 function may contribute to the neurodegeneration in Huntington disease | constitutional
| germinal mutation
|  
|  
|  
|
associated with foetal akinesia deformation sequence/lethal multiple pterygium syndrome | |
Susceptibility
|
to aneurysmatic subarachnoid hemorrhage |
Variant & Polymorphism
other
| rare RYR1 variants in patients suffering from aneurysmatic subarachnoid hemorrhage |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neuromuscular | | | |
RyR activity may not be irreversibly damaged in patients with SEPN1-associated disease and might provide a target for therapeutic intervention | neurology | | | |
altered RYR function is involved in neuronal cell death, and its stabilization might be beneficial for treatment of Huntington disease (dantrolene or other similar RYR inhibitors may be beneficial for HD patients) |
| | | |